Biocept, Inc. announced the appointments of Samuel D. Riccitelli as Interim President succeeding Michael W. Nall. Biocept also named M. Faye Wilson as Lead Independent Director of the company's Board of Directors. Mr. Riccitelli remains Chair of the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | 0.00% | -99.76% |
Apr. 26 | Motion for Asset Sale Approved for Biocept, Inc. | CI |
Apr. 02 | Motion for Asset Sale Approved for Biocept, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-99.76% | 262 | |
-4.67% | 12.32B | |
-5.19% | 8.07B | |
+9.45% | 5.92B | |
+28.50% | 5.52B | |
-8.09% | 4.21B | |
-55.31% | 2.99B | |
+13.49% | 2.73B | |
-1.34% | 2.43B | |
+32.24% | 2.29B |
- Stock Market
- Equities
- BIOCQ Stock
- News Biocept, Inc.
- Biocept, Inc. Announce Executive Changes